Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China flag China · Delayed Price · Currency is CNY
102.59
+1.84 (1.83%)
At close: Mar 6, 2026

SHA:688198 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
630.37500.26369.91295.07251.8
Other Revenue
-1.610.730.10.02
630.37501.88370.64295.17251.82
Revenue Growth (YoY)
25.60%35.41%25.57%17.21%38.42%
Cost of Revenue
-58.5237.6431.3629.61
Gross Profit
630.37443.35333263.81222.21
Selling, General & Admin
-154.92131.97123.77131.16
Research & Development
-151.4498.8155.1558.9
Other Operating Expenses
4073.461.251.621.17
Operating Expenses
407312.22233.5181.64192.04
Operating Income
223.37131.1499.582.1730.17
Interest Expense
--0.46-0.41-0.08-0.12
Interest & Investment Income
-17.3217.6622.5316.49
Currency Exchange Gain (Loss)
-0.05-0.260-
Other Non Operating Income (Expenses)
-5.86-0.16-0.06-0.68-0.05
EBT Excluding Unusual Items
217.51147.89116.43103.9446.5
Gain (Loss) on Sale of Investments
-0.7410.890.97
Gain (Loss) on Sale of Assets
--0.050.05-0.01-0.02
Other Unusual Items
-2.22.541.322.31
Pretax Income
217.51150.79120.02106.1449.76
Income Tax Expense
17.3218.6410.6111.74-1.51
Earnings From Continuing Operations
200.19132.14109.4194.3951.26
Minority Interest in Earnings
-14.195.80.73-0.06
Net Income
200.19146.33115.2195.1351.2
Net Income to Common
200.19146.33115.2195.1351.2
Net Income Growth
36.81%27.02%21.11%85.80%-9.42%
Shares Outstanding (Basic)
137137136136135
Shares Outstanding (Diluted)
137137137136135
Shares Change (YoY)
0.26%-0.29%0.92%0.86%0.44%
EPS (Basic)
1.461.070.850.700.38
EPS (Diluted)
1.461.070.840.700.38
EPS Growth
36.45%27.38%20.00%84.21%-9.82%
Free Cash Flow
--27.0212.5324.014.27
Free Cash Flow Per Share
--0.200.090.180.03
Dividend Per Share
-0.8000.8000.5000.357
Dividend Growth
--60.00%40.02%149.90%
Gross Margin
100.00%88.34%89.84%89.38%88.24%
Operating Margin
35.43%26.13%26.85%27.84%11.98%
Profit Margin
31.76%29.16%31.08%32.23%20.33%
Free Cash Flow Margin
--5.38%3.38%8.14%1.70%
EBITDA
242.68150.45110.787.7836.19
EBITDA Margin
38.50%29.98%29.87%29.74%14.37%
D&A For EBITDA
19.3119.3111.195.616.02
EBIT
223.37131.1499.582.1730.17
EBIT Margin
35.43%26.13%26.85%27.84%11.98%
Effective Tax Rate
7.96%12.36%8.84%11.06%-
Revenue as Reported
-501.88370.64295.17251.82
Advertising Expenses
-2.010.371.121.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.